Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Camel Milk for Chronic Hepatitis C
NCT02216045Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2014
- Primary completion
- Feb 2015
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Early Virologic Response at 4 weeks. Started Jun 2014; status: completed.
Beyond the preview
Go deeper on NCT02216045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02216045.